Pharmacokinetic analysis of bumped-kinase inhibitors in horses demonstrates their potential utility for prevention and treatment of equine protozoal myeloencephalitis.
Abstract: To determine the systemic and CNS distribution of bumped-kinase inhibitors (BKIs) in healthy horses, assess potential side effects, and identify a candidate compound for a clinical trial in equine protozoal myeloencephalitis (EPM) cases. Unassigned: 9 pharmacokinetic (PK) experiments were conducted from March 2021 through November 2024. Bumped-kinase inhibitors 1708, 1748, and 1841 were screened in Sarcocystis neurona growth assays and IV PKs, followed by investigation of a lead BKI compound by single-dose or multiday oral administration. Serial plasma collections were performed to assess systemic distribution, and CNS penetration was determined based on drug concentrations in CSF and nervous tissue. Side effects were monitored by daily physical examinations, CBC, and blood biochemistry. Unassigned: BKI-1708 was identified as a lead compound based on in vitro inhibition of S neurona growth at low nanomolar concentrations (half-maximum inhibitory concentration, 42 nM) and a lack of side effects. Based on IV and oral PK studies, a single daily dose was sufficient to achieve therapeutic concentrations systemically (average peak concentration of 5 μM and half-life of 25 hours at steady state). However, BKI-1708 concentrations in CSF and nervous tissue were 25-fold lower than in plasma, suggesting low CNS penetration. Unassigned: Although BKI-1708 did not achieve therapeutic concentrations in the CNS, the systemic PK profile warrants further investigation for use as EPM prophylaxis based on intermittent drug administration. Unassigned: BKI-1708 is a potential compound for EPM prevention and treatment of systemic apicomplexan-related diseases in horses, such as piroplasmosis.
Publication Date: 2025-10-14 PubMed ID: 41086839DOI: 10.2460/ajvr.25.07.0270Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Cite This Article
APA
Rocha IA, McPeek JL, Hulverson MA, Choi R, Orr K, Sponseller BT, Kennedy T, Ojo KK, Barrett LK, Ruby R, Janes J, Reed SM, Arnold SLM, Van Voorhis WC, Page A, Howe DK.
(2025).
Pharmacokinetic analysis of bumped-kinase inhibitors in horses demonstrates their potential utility for prevention and treatment of equine protozoal myeloencephalitis.
Am J Vet Res, 87(1), ajvr.25.07.0270.
https://doi.org/10.2460/ajvr.25.07.0270 Publication
Researcher Affiliations
- Department of Veterinary Science, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY.
- Department of Veterinary Science, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY.
- Center for Emerging and Re-emerging Infectious Diseases, Department of Medicine, Division of Allergy and Infectious Disease, School of Medicine, University of Washington, Seattle, WA.
- Center for Emerging and Re-emerging Infectious Diseases, Department of Medicine, Division of Allergy and Infectious Disease, School of Medicine, University of Washington, Seattle, WA.
- Rood and Riddle Equine Hospital, Lexington, KY.
- Department of Veterinary Science, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY.
- Eleven Bravo LLC, Westport, WI.
- Center for Emerging and Re-emerging Infectious Diseases, Department of Medicine, Division of Allergy and Infectious Disease, School of Medicine, University of Washington, Seattle, WA.
- Center for Emerging and Re-emerging Infectious Diseases, Department of Medicine, Division of Allergy and Infectious Disease, School of Medicine, University of Washington, Seattle, WA.
- Department of Veterinary Science, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY.
- Department of Veterinary Science, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY.
- Department of Veterinary Science, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY.
- Rood and Riddle Equine Hospital, Lexington, KY.
- Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA.
- Center for Emerging and Re-emerging Infectious Diseases, Department of Medicine, Division of Allergy and Infectious Disease, School of Medicine, University of Washington, Seattle, WA.
- Department of Veterinary Science, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY.
- Department of Veterinary Science, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY.
MeSH Terms
- Animals
- Horses
- Horse Diseases / prevention & control
- Horse Diseases / drug therapy
- Horse Diseases / parasitology
- Sarcocystis / drug effects
- Encephalomyelitis / veterinary
- Encephalomyelitis / prevention & control
- Encephalomyelitis / drug therapy
- Encephalomyelitis / parasitology
- Protein Kinase Inhibitors / pharmacokinetics
- Protein Kinase Inhibitors / therapeutic use
- Sarcocystosis / veterinary
- Sarcocystosis / prevention & control
- Sarcocystosis / drug therapy
- Female
- Male
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
